Serdar Ekrem Bulun

Serdar Ekrem Bulun's AcademicInfluence.com Rankings

Serdar Ekrem Bulun

Biology

#8874

World Rank

#12011

Historical Rank

Endocrinology

#100

World Rank

#111

Historical Rank

biology Degrees

Download Badge

Biology

Serdar Ekrem Bulun's Degrees

PhD Biology Istanbul University
Masters Biology Istanbul University
Bachelors Biology Istanbul University

Similar Degrees You Can Earn

Why Is Serdar Ekrem Bulun Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Serdar Ekrem Bulun's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Estrogen production and action. (2001) (719)
Aromatase expression in endometriosis. (1996) (554)
Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment (2005) (503)
Progesterone receptor isoform A but not B is expressed in endometriosis. (2000) (468)
Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. (1997) (425)
Aromatase expression in health and disease. (1997) (368)
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. (2013) (366)
Uterine fibroids. (2013) (352)
A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. (1993) (351)
Progesterone resistance in endometriosis: Link to failure to metabolize estradiol (2006) (351)
The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters (2003) (324)
Progesterone is essential for maintenance and growth of uterine leiomyoma. (2010) (303)
Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol (1998) (293)
Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1 (2007) (273)
Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. (1996) (271)
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. (1998) (251)
Aromatase P450 Gene Expression in Human Adipose Tissue. ROLE OF A Jak/STAT PATHWAY IN REGULATION OF THE ADIPOSE-SPECIFIC PROMOTER (*) (1995) (237)
Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. (1999) (229)
Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. (2004) (225)
Aromatase and other steroidogenic genes in endometriosis: translational aspects. (2006) (219)
Role of Estrogen Receptor-β in Endometriosis (2012) (218)
Anastrazole and oral contraceptives: a novel treatment for endometriosis. (2005) (211)
Expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage (1997) (209)
Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. (1999) (207)
A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. (2001) (198)
Endometriosis. (2019) (190)
Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. (1996) (187)
Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. (2009) (184)
Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. (2010) (183)
Aromatase inhibitors: the next generation of therapeutics for endometriosis? (2006) (182)
Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. (1994) (181)
Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis. (2007) (180)
Aromatase, breast cancer and obesity: a complex interaction (2012) (178)
Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. (2001) (173)
Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. (2000) (166)
Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. (1994) (156)
Genome-Wide DNA Methylation Analysis Predicts an Epigenetic Switch for GATA Factor Expression in Endometriosis (2014) (152)
A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription [published erratum appears in J Clin Endocrinol Metab 1994 Feb;78(2):494] (1993) (151)
Endocrine disorders associated with inappropriately high aromatase expression (1997) (147)
Aromatase in endometriosis and uterine leiomyomata (2005) (144)
Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. (2009) (142)
Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth (2013) (140)
Endometriosis and Ovarian Cancer: A Review of Clinical, Pathologic, and Molecular Aspects (2011) (138)
Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells (1996) (136)
Feminizing Sertoli Cell Tumors in Boys with Peutz‐Jeghers Syndrome (1995) (133)
Estrogen Production and Metabolism in Endometriosis (2002) (131)
Aromatase and endometriosis. (2004) (130)
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. (2008) (129)
Aromatase expression and regulation in breast and endometrial cancer. (2016) (129)
Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. (1999) (128)
High aromatase expression in uterine leiomyoma tissues of African-American women. (2009) (127)
Role of aromatase in endometrial disease (2001) (127)
Role of Stem Cells in Human Uterine Leiomyoma Growth (2012) (127)
Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. (1998) (124)
The Physiology and Pathology of the Female Reproductive Axis (2007) (124)
Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. (2001) (121)
Organization of the human aromatase p450 (CYP19) gene. (2004) (121)
CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. (1994) (118)
Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. (1993) (116)
Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications. (2015) (113)
Steroid receptor and aromatase expression in baboon endometriotic lesions. (2003) (113)
Molecular basis for treating endometriosis with aromatase inhibitors. (2000) (111)
A Modified Baboon Model for Endometriosis (2002) (108)
Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis. (2009) (108)
Genome-Wide DNA Methylation Indicates Silencing of Tumor Suppressor Genes in Uterine Leiomyoma (2012) (107)
Aromatase gene expression in adipose tissue: Relationship to breast cancer (1994) (101)
Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. (2007) (99)
Endometriosis and nuclear receptors. (2019) (98)
Interleukin-1β Elevates Cyclooxygenase-2 Protein Level and Enzyme Activity via Increasing Its mRNA Stability in Human Endometrial Stromal Cells: An Effect Mediated by Extracellularly Regulated Kinases 1 and 2 (2002) (98)
Progestins activate the AKT pathway in leiomyoma cells and promote survival. (2009) (97)
Steroid hormones and leiomyomas. (2006) (97)
Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells. (2004) (96)
Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2. (2001) (95)
Mechanisms of excessive estrogen formation in endometriosis. (2002) (94)
Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. (2007) (94)
Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. (2002) (94)
Molecular Biology of Endometriosis: From Aromatase to Genomic Abnormalities (2015) (92)
Aromatase in aging women. (1999) (90)
Endometriosis: the ultimate hormonal disease. (2003) (89)
Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. (2004) (89)
Aromatase excess in cancers of breast, endometrium and ovary (2007) (89)
Menstruation: science and society (2020) (88)
Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua. (1993) (88)
Genetics of endocrine disease: A highly complex organization of the regulatory region of the human CYP19 (Aromatase) gene revealed by the human genome project (2001) (85)
Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. (2002) (84)
Genome-Wide Progesterone Receptor Binding: Cell Type-Specific and Shared Mechanisms in T47D Breast Cancer Cells and Primary Leiomyoma Cells (2012) (84)
Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6. (1998) (84)
Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. (2010) (83)
Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. (2002) (82)
Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase. (2002) (81)
Regulation of Aromatase Expression in Breast Cancer Tissue (2009) (80)
17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis. (2010) (80)
Regulation of breast cancer-associated aromatase promoters. (2009) (77)
Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts. (2007) (77)
Aromatase and estrogen receptor α deficiency. (2014) (76)
Steroidogenic factor-1 and endometriosis (2009) (74)
Regulation of aromatase expression in human tissues (2004) (74)
Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene (2003) (74)
Aromatase inhibitors for the treatment of endometriosis. (2012) (73)
CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism (2019) (71)
Clinical review 78: Aromatase deficiency in women and men: would you have predicted the phenotypes? (1996) (70)
Aromatase expression in women's cancers. (2008) (69)
Tissue‐Specific Estrogen Biosynthesis and Metabolism (2001) (68)
Up-regulation of Cyclooxygenase-2 Expression and Prostaglandin Synthesis in Endometrial Stromal Cells by Malignant Endometrial Epithelial Cells (2002) (67)
Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. (1998) (67)
Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. (1996) (66)
WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells. (2002) (65)
Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene. (2007) (65)
WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells (2003) (65)
Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth (2014) (64)
Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. (2008) (64)
Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. (1997) (64)
Altered retinoid uptake and action contributes to cell survival in endometriosis. (2010) (62)
Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues. (2000) (61)
Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo. (2015) (58)
Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. (2008) (57)
Epithelial Mutations in Endometriosis: Link to Ovarian Cancer. (2019) (57)
Aromatase expression in a feminizing adrenocortical tumor. (1996) (56)
Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism. (2007) (54)
Intact progesterone receptors are essential to counteract the proliferative effect of estradiol in a genetically engineered mouse model of endometriosis. (2004) (53)
Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. (2002) (52)
Reactive Oxygen Species Mediate Mitogenic Growth Factor Signaling Pathways in Human Leiomyoma Smooth Muscle Cells1 (2010) (52)
CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity (2008) (50)
Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. (1994) (50)
ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis. (2014) (49)
The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells. (2010) (49)
Hypermethylation of the CpG Island Spanning From Exon II to Intron III is Associated With Steroidogenic Factor 1 Expression in Stromal Cells of Endometriosis (2011) (49)
Aromatase as a Therapeutic Target in Endometriosis (2000) (49)
Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution (2015) (49)
Uterine Leiomyoma Stem Cells: Linking Progesterone to Growth (2015) (48)
Adenosine A1 receptor, a target and regulator of ERα action, mediates the proliferative effects of estradiol in breast cancer (2009) (47)
A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase Promoters I.3 and II by Disrupting a Transcriptional Complex in Breast Adipose Fibroblasts* (2006) (46)
Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action. (2011) (46)
Literature Review on the Role of Uterine Fibroids in Endometrial Function (2018) (45)
Aromatase inhibition for refractory endometriosis-related chronic pelvic pain. (2011) (44)
BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells. (2006) (44)
Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation. (2013) (44)
SP1 and SP3 Mediate Progesterone-Dependent Induction of the 17beta Hydroxysteroid Dehydrogenase Type 2 Gene in Human Endometrium1 (2006) (43)
Cellular characterization of adipose tissue from various body sites of women. (1996) (42)
A call for more transparency of registered clinical trials on endometriosis. (2009) (41)
5-Hydroxymethylcytosine promotes proliferation of human uterine leiomyoma: a biological link to a new epigenetic modification in benign tumors. (2014) (41)
Aromatase Promoter I.f is Regulated by Estrogen Receptor Alpha (ESR1) in Mouse Hypothalamic Neuronal Cell Lines1 (2009) (40)
Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms. (2011) (40)
Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 Pathway (2018) (39)
Aromatase deficiency and estrogen resistance: from molecular genetics to clinic. (2000) (39)
A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue (2009) (39)
Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19 (2018) (38)
Estrogen biosynthesis in adipose tissue: regulation by paracrine and autocrine mechanisms. (1996) (38)
Decreased expression of microRNA-29 family in leiomyoma contributes to increased major fibrillar collagen production. (2016) (37)
Estrogen receptor-beta mediates cyclooxygenase-2 expression and vascular prostanoid levels in human placental villous endothelial cells. (2009) (36)
Novel Promoter I.8 and Promoter Usage in the CYP19 (Aromatase) Gene (2008) (36)
Breast cancer and expression of aromatase in breast adipose tissue (1994) (35)
Estrogen receptor β regulates endometriotic cell survival through serum and glucocorticoid-regulated kinase activation. (2016) (35)
Estrogen regulates expression of tumor necrosis factor receptors in breast adipose fibroblasts. (2004) (35)
Predictors of response to aromatase inhibitors (2007) (33)
Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR. (1995) (32)
Mechanisms of Disease Endometriosis (2008) (31)
Estrogen receptor-β and fetoplacental endothelial prostanoid biosynthesis: a link to clinically demonstrated fetal growth restriction. (2011) (30)
Tissue-Specific Stem Cells in the Myometrium and Tumor-Initiating Cells in Leiomyoma1 (2014) (30)
Regulation of 17-Beta Hydroxysteroid Dehydrogenase Type 2 in Human Placental Endothelial Cells1 (2007) (30)
Adenomyosis pathogenesis: insights from next-generation sequencing (2021) (29)
Methylation of a Novel CpG Island of Intron 1 Is Associated With Steroidogenic Factor 1 Expression in Endometriotic Stromal Cells (2014) (29)
Diagnosis of Intra-amniotic Infection by Proteomic Profiling and Identification of Novel Biomarkers (2006) (29)
Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II. (2007) (29)
Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma (2018) (28)
A humanized pattern of aromatase expression is associated with mammary hyperplasia in mice. (2012) (27)
Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells. (2009) (27)
Shift from androgen to estrogen action causes abdominal muscle fibrosis, atrophy, and inguinal hernia in a transgenic male mouse model (2018) (26)
Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression. (2013) (25)
JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters. (2011) (25)
CHAPTER 17 – Physiology and Pathology of the Female Reproductive Axis (2011) (25)
CD34 and CD49f Double-Positive and Lineage Marker-Negative Cells Isolated from Human Myometrium Exhibit Stem Cell-Like Properties Involved in Pregnancy-Induced Uterine Remodeling (2015) (24)
Activated glucocorticoid and eicosanoid pathways in endometriosis. (2012) (24)
AMP-activated protein kinase and energy balance in breast cancer. (2017) (24)
Aberrant expression and localization of deoxyribonucleic acid methyltransferase 3B in endometriotic stromal cells. (2015) (23)
Dysfunctional MnSOD leads to redox dysregulation and activation of prosurvival AKT signaling in uterine leiomyomas (2016) (23)
Estrogen Receptor- β , Estrogen Receptor- α , and Progesterone Resistance in Endometriosis (2011) (23)
Expression profiling of nuclear receptors identifies key roles of NR4A subfamily in uterine fibroids. (2013) (23)
Induction of cyclooxygenase-2 in human endometrial stromal cells by malignant endometrial epithelial cells: evidence for the involvement of extracellularly regulated kinases and CCAAT/enhancer binding proteins. (2003) (22)
CCAAT/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma. (2008) (22)
Aromatase gene expression in adipose tissue: relationship to breast cancer. (1994) (22)
Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons. (2013) (22)
Phosphatidylinositol 3-Kinase Activity Is Critical for Glucose Metabolism and Embryo Survival in Murine Blastocysts (2007) (21)
HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma. (2020) (18)
Paracrine-stimulated gene expression profile favors estradiol production in breast tumors (2006) (18)
Cutting SRC-1 down to size in endometriosis (2012) (18)
RANKL/RANK Pathway and Its Inhibitor RANK-Fc in Uterine Leiomyoma Growth (2018) (18)
Erratum to “Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells” [Mol. Cell. Endocrinol. 118 (1996) 215–220] (1996) (18)
ESTROGEN-DEPENDENT SUSHI DOMAIN CONTAINING 3 REGULATES CYTOSKELETON ORGANIZATION AND MIGRATION IN BREAST CANCER CELLS (2014) (18)
Progesterone receptor action in leiomyoma and endometrial cancer. (2009) (18)
Weight gain increases human aromatase expression in mammary gland (2012) (18)
Altered retinoid signaling compromises decidualization in human endometriotic stromal cells. (2017) (17)
Erratum: Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads (Journal of Clinical Endocrinology and Metabolism (1993) 77 (1616-1621)) (1994) (17)
The Essential Role of GATA6 in the Activation of Estrogen Synthesis in Endometriosis (2019) (17)
Ovarian endometriosis: the nemesis of eggs. (2014) (16)
Fenretinide: A Novel Treatment for Endometrial Cancer (2014) (15)
Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer. (2011) (15)
Application of ex-vivo spheroid model system for the analysis of senescence and senolytic phenotypes in uterine leiomyoma (2018) (15)
The AKT/BCL-2 Axis Mediates Survival of Uterine Leiomyoma in a Novel 3D Spheroid Model (2018) (15)
A statement on abortion by 100 professors of obstetrics: 40 years later. (2013) (15)
Gut microbiota–derived short-chain fatty acids protect against the progression of endometriosis (2021) (15)
Erratum: A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription (Journal of Clinical Endocrinology and Metabolism (1993) 77 (1622-1 (1994) (14)
Targeting DNA Methylation Depletes Uterine Leiomyoma Stem Cell–enriched Population by Stimulating Their Differentiation (2020) (14)
Brain Aromatase and the Regulation of Sexual Activity in Male Mice (2020) (13)
Effects of Conditioned Medium from Different Cultured Cell Types on Aromatase Expression in Adipose Stromal Cells (1995) (13)
Paracrine Pathways in Uterine Leiomyoma Stem Cells Involve Insulinlike Growth Factor 2 and Insulin Receptor A (2017) (12)
Fenretinide:A Potential Treatment for Endometriosis (2016) (12)
Glucocorticoid-induction of hypothalamic aromatase via its brain-specific promoter (2012) (12)
Adiposity Results in Metabolic and Inflammation Differences in Premenopausal and Postmenopausal Women Consistent with the Difference in Breast Cancer Risk (2018) (11)
Activation of protein kinase B by WNT4 as a regulator of uterine leiomyoma stem cell function. (2020) (11)
Aromatase promoter I.f is regulated by progesterone receptor in mouse hypothalamic neuronal cell lines. (2011) (11)
Implantation and Placental Development (2016) (11)
Treatment of endometriosis-related chronic pelvic pain with Ulipristal Acetate and associated endometrial changes. (2017) (10)
Aromatase in health and disease (2003) (10)
Early growth response-2 expression in uterine leiomyoma cells: regulation and function. (2011) (10)
Steroids, Cytokines, and Implantation. (2017) (10)
Gene Expression Profiling of Leiomyoma and Myometrial Smooth Muscle Cells in Response to Transforming Growth Factor-β (2006) (10)
Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Modulates Human Endometrial Cancer Cell Survival (2013) (9)
Progesterone resistance and endometrial disease. Preface. (2010) (9)
Progesterone receptor-DNA methylation crosstalk regulates depletion of uterine leiomyoma stem cells: A potential therapeutic target (2021) (8)
GATA2 and progesterone receptor interaction in endometrial stromal cells undergoing decidualization. (2020) (8)
Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution (2021) (8)
Transcription factor 21 regulates expression of ERβ and SF-1 via upstream stimulatory factor-2 in endometriotic tissues. (2018) (8)
Estrogen receptor alpha (Esr1) regulates aromatase (Cyp19a1) expression in the mouse brain. (2015) (8)
A statement on abortion by 100 professors of obstetrics: 40 years later. (2013) (7)
Aromatase, microRNA, and inflammation: a complex relationship. (2016) (7)
MeDEStrand: an improved method to infer genome-wide absolute methylation levels from DNA enrichment data (2018) (7)
Estrogen and Pelvic Organ Prolapse (2016) (7)
Expression of Estrogen-Related Gene Markers in Breast Cancer Tissue Predicts Aromatase Inhibitor Responsiveness (2013) (7)
Aryl Hydrocarbon Receptor-Mediated Transcription: Ligand-Dependent Recruitment of Estrogen Receptor α to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin-Responsive Promoters (2006) (7)
Ovulation induction in women with infertility: a new indication for aromatase inhibitors. (2003) (7)
Whole-Genome Sequencing and Target Validation Analysis of Müllerian Adenosarcoma: A Tumor With Complex but Specific Genetic Alterations (2020) (7)
Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma. (2016) (7)
Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia (2020) (6)
ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics. (2021) (5)
PLIN2 Functions as a Novel Link between Progesterone Signaling and Metabolism in Uterine Leiomyoma Cells. (2019) (5)
Regulation of 17-hydroxysteroid dehydrogenase type 2 in placental endothelial cells (2006) (5)
LAT1 Regulates Growth of Uterine Leiomyoma Smooth Muscle Cells (2010) (5)
Fenretinide: a potential treatment for endometriosis (2014) (5)
Baseline Endometrial Thickness or Endometrial Thickness Change in Response to Estrogen Is Not Predictive of Frozen Embryo Transfer Success in Medicated Cycles (2020) (4)
Summary of the Proceedings of the Basic Science of Uterine Fibroids Meeting: New Developments February 28, 2020. (2020) (4)
Tumor Necrosis Factor a and Interleukin 11 Secreted by Malignant Breast Epithelial Cells Inhibit Adipocyte Differentiation by Selectively Down-Regulating CCAAT / Enhancer Binding Protein a and Peroxisome Proliferator-activated Receptor g : Mechanism of Desmoplastic Reaction 1 (2001) (4)
AROMATASE DEFICIENCY (2014) (4)
Single-cell sequencing reveals novel cellular heterogeneity in uterine leiomyomas. (2022) (4)
Tissue Stem Cells and Uterine Physiology and Pathology (2015) (4)
Tumor and Stem Cell Biology Cancer Research Transcription Factor KLF 11 Integrates Progesterone Receptor Signaling and Proliferation in Uterine Leiomyoma Cells (2010) (4)
The Aromatase Reaction (1996) (3)
Uterine Leiomyosarcoma Associated With Leiomyoma With Bizarre Nuclei: Histology and Genomic Analysis of 2 Cases. (2022) (3)
The syndrome of aromatase deficiency (1998) (3)
Tryptophan 2,3-Dioxygenase-2 in Uterine Leiomyoma: Dysregulation by MED12 Mutation Status (2022) (3)
Mesenchymal-epithelial interactions and breast cancer – role of local estrogen production (1997) (3)
Mono-(2-ethyl-5-hydroxyhexyl) phthalate promotes uterine leiomyoma cell survival through tryptophan-kynurenine-AHR pathway activation (2022) (2)
Molecular basis for increased extraglandular aromatization of plasma C19 steroids resulting in prepubertal gynecomastia (1995) (2)
Aromatase: Update and New Roles in Reproductive Disease. Preface (2004) (2)
AROMATASE INHIBITORS FOR THE TREATMENT OF ENDOMETRIOSIS: A REVIEW (2012) (2)
Erratum: CCAAT/Enhancer binding protein β regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma (Journal of Clinical Endocrinology and Metabolism (2008) 93 (981-991)) (2009) (2)
CD 34 and CD 49 f Double-Positive and Lineage Marker-Negative Cells Isolated from Human Myometrium Exhibit Stem Cell-Like Properties Involved in Pregnancy-Induced Uterine Remodeling 1 (2019) (2)
Genome-wide estrogen receptor-α binding and action in human endometrial stromal cells. (2020) (2)
Medical Therapies: Aromatase Inhibitors (2012) (2)
OR09-03 Brain Aromatase Is Essential for Regulation of Sexual Activity in Male Mice (2020) (1)
1 Changes in Aromatase ( CYP 19 ) Gene Promoter Usage in Non-Small Cell Lung Cancer (2017) (1)
Regulatory mechanisms in transcriptional signaling (2009) (1)
416: Estrogen receptor-beta (ESR2) inhibits induction of hypoxia-mediated genes critical for normal fetoplacental vascular angiogenesis (2012) (1)
Ulipristal acetate regulates perilipin-2 gene expression through progesterone receptor isoform B in uterine leiomyoma cells (2017) (1)
Endometriosis caused by retrograde menstruation: now demonstrated by DNA evidence. (2022) (1)
In Vivo Genome-Wide PGR Binding in Pregnant Human Myometrium Identifies Potential Regulators of Labor (2022) (1)
Aromatase inhibitors: The next wave in treatment of endometriosis? (2006) (1)
Midlife Urinary Phthalate Metabolite Concentrations and Prior Uterine Fibroid Diagnosis (2022) (1)
Epigenomic and enhancer dysregulation in uterine leiomyomas. (2022) (1)
Activation of AKT by WNT4 as a regulator of uterine leiomyoma stem cell function (2020) (1)
The Role of Matrix Metalloproteinase-11 (MMP11) in Human Uterine Leiomyomas. (2012) (1)
Retinoic acid action is altered within endometrium of baboons affected with endometriosis (2022) (1)
Single Cell atlas of uterine myometrium and leiomyomas reveals diverse and novel cell types of non-monoclonal origin (2020) (1)
Phthalates and Phthalate Alternatives: Effects on Proliferative and Estrogenic Target Genes in Ishikawa Cells (2014) (1)
Silibinin inhibitis progesterone induced RANKL expression in human uterine leiomyoma cells (2016) (1)
Treatment of severe endometriosis with an aromatase inhibitor: A novel indication and its molecular basis (1998) (1)
Innovations in Reproductive Endocrinology: A Tribute to Bruce Carr, MD (2015) (1)
Growth Retardation and Abnormal Maternal Behavior in Mice Lacking Testicular Orphan Nuclear Receptor 4 (2006) (0)
P-567: Role of microRNAs in human uterine leiomyoma pathogenesis and growth (2006) (0)
Abstract 2102: Phenformin down-regulates mammary aromatase expression via the AMPK pathway in humanized aromatase expressing ERBB2 mice (2014) (0)
ERβ inhibits PR expression in endometrium and endometriosis (2008) (0)
Counting human somatic cell replications: Methylation mirrors endometrial stem cell divisionsKim JY, Tavaré S, Shibata D (Univ of Southern California, Los Angeles; Univ of Cambridge, England) Proc Natl Acad Sci U S A 102:17739–17744, 2005§ (2007) (0)
An Estrogen-Related Gene Signature in Breast Cancer Tissue Predicts Responsiveness to Aromatase Inhibitors (2010) (0)
Histological and molecular analysis of cellular leiomyoma with sclerosis: linked to HMGA2 overexpression (2022) (0)
T. Rajendra Kumar, PhD (2017) (0)
Abstract B46: CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb Repressive complex 2 via a H3K27M-like mechanism (2020) (0)
Comparison of Fine-Scale Recombination Rates in Humans and ChimpanzeesWinckler W, Myers SR, Richter DJ, et al (Massachusetts Gen Hosp, Boston; Harvard Med School, Boston; Broad Inst of Harvard and MIT, Cambridge, Mass; et al) Science 308:107–111, 2005§ (2006) (0)
Uterine fibroids and the endometrium (2017) (0)
14: The role of estrogen receptor-β (ESR2) on fetoplacental vascular function (2008) (0)
RF03 | PMON302 A Unique Estrogen-Sensitive Fibroblast Population Drives Abdominal Muscle Fibrosis (2022) (0)
713: Impaired fetoplacental angiogenesis in fetal growth restriction is mediated by hypoxia inducible factor 1-beta (HIF1β) (2014) (0)
Maintaining endometrial stromal stem cells in a non-scaffold based 3D culture system (2019) (0)
[Endometriosis and aromatase inhibitor]. (2001) (0)
Leptin increases VEGF and VEGF-receptor expression in human uterine leiomyoma cells in vitro (2007) (0)
O-3: Differential expression of SF-1 (steroidogenic factor-1) in endometrial and endometriotic stromal cells: Regulation by methylation (2006) (0)
Type I procollagen COOH-terminal proteinase enhancer (PCOLCE) and its protein product procollagen C-endopeptidase enhancer-1 (PCPE-1) are differentially expressed in leiomyoma versus myometrium (2008) (0)
ERβ regulates ERα expression and response to estradiol via specific promoters in endometrium and endometriosis (2007) (0)
Introduction to Guest Editor (2013) (0)
Endometriosis Expresses a Gene Expression Pattern Suggesting Decreased Retinoid Uptake and Metabolism (2009) (0)
Why the bulge?: the differential expression of elastic fibril components in leiomyoma (LEIO) and myometrium (MYO) and effects of estradiol treatment (2010) (0)
The Biology of Endometriosis: Aromatase and Endometriosis (2005) (0)
Sodium butyrate (NaBu) decreases proliferation of stromal cells derived from endometriosis and Ishikawa cells in culture (2007) (0)
Role of SUSHI domain containing 3 (SUSD3) in breast cancer and aromatase inhibitor responsiveness (2010) (0)
MeDEStrand: an improved method to infer genome-wide absolute methylation level from DNA enrichment experiment (2017) (0)
Transcriptional regulation of the CYP1A1 gene by dioxin in eutopic endometrial and endometriotic stromal cells. (2001) (0)
O-76 : Taurine transporter (TauT), a novel target of sodium butyrate in supression of aromatase expression in stromal cells derived from endometriosis (2006) (0)
Transforming growth factor beta upregulates collagen via the suppression of microrna-29 expression in leiomyoma (2012) (0)
SAT-749 Defining The Role Of Androgens In Hernia Associated Skeletal Muscle Fibrosis (2020) (0)
Chapter 131 – Uterine Fibroids (2016) (0)
From a little “SPARC” bursts a flame: differential expression and regulation of secreted protein acidic and rich in cysteine (SPARC) in leiomyoma and myometrium (2011) (0)
Several Apoptosis Related Genes Differentially Expressed in Human Granulosa Cells of the Embryos With Different Developmental Potential (2009) (0)
Wilms’ tumor 1 inhibits aromatase P450 expression in human cells and is downregulated in endometriosis vs. endometrium-derived stromal cells (2002) (0)
Engineered MED12 mutations drive uterine fibroid-like transcriptional and metabolic programs by altering the 3D genome compartmentalization (2023) (0)
THE ROLE OF TRYPTOPHAN 2,3-DIOXYGENASE IN HUMAN UTERINE LEIOMYOMA HARBORING MED12 MUTATION (2020) (0)
A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase Promoters 1.3 and II by Disrupting a Transcriptional Complex in Breast Adipose FibroblastsDeb S, Zhou J, Amin SA, et al (Northwestern Univ, Chicago) J Biol Chem 281:2585–2597, 2006§ (2007) (0)
Ovulated oocytes in adult mice derive from non-circulating germ cellsEggan K, Jurga S, Gosden R, et al (Harvard Univ, Cambridge, Mass; Harvard Med School, Boston; Harvard Stem Cell Inst, Cambridge, Mass; et al) Nature 441:1109–1114, 2006§ (2007) (0)
Induction of cyclooxygenase-2 and prostaglandin E2 biosynthesis by epithelial cell derived factors is mediated mainly by p42/p44 mitogen-activated protein (MAP) kinase in stromal cells in endometrium. (2001) (0)
Alterations in retinoid signaling in endometriosis may lead to differences in decidualization (2011) (0)
Cellular Localization of Green Fluorescent Protein (GFP)-tagged Sushi Domain Containing 3 (SUSD3) in T47D Breast Cancer Cells (2011) (0)
Tommaso Falcone, MD, FRCS(C), FACOG (2016) (0)
Loss of Dystrophin is common in Uterine Leiomyosarcoma: a potential biomarker for clinical application. (2022) (0)
Cassing Hammond, MD (2016) (0)
Steroidogenesis in endometriosis: the importance of GATA6 (2015) (0)
Presidents's Message (1993) (0)
Aromatase expression in uterine leiomyomata is regulated by alternative promoters (2004) (0)
200: Fetoplacental endothelium demonstrate unique responses to physiologic hypoxemia (2012) (0)
Sushi domain containing 3 (SUSD3) and its role in breast cancer cell morphology, migration, and adhesion (2011) (0)
NOBOX Deficiency Disrupts Early Folliculogenesis and Oocyte-Specific Gene ExpressionRajkovic A, Pangas SA, Ballow D, et al (Baylor College of Medicine, Houston) Science 305:1157–1159, 2004§ (2006) (0)
Erratum: A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts (Journal of Biological Chemistry (2006) 281 (2585-2597)) (2006) (0)
SINGLE CELL ANALYSIS REVEALS HETEROGENEITY IN THE DISEASE RELEVANT CELL TYPES OF ADENOMYOSIS (2021) (0)
Endometriosis and adenomyosis: shared pathophysiology. (2023) (0)
218: Estrogen receptor—mediated regulation of fetoplacental endothelial prostanoid synthases in fetal growth restriction (2009) (0)
The human myometrial transcriptome uncovers pathways associated with spontaneous labor: 668 (2019) (0)
Use of Transgenic Knockout Mice to Understand the Roles of Estrogen and Progesterone in the Growth of Ectopic Uterine Tissue as a Model for Endometriosis (2000) (0)
Ovarian Aging, from Bench to Bedside (2015) (0)
Abstract 90: Estrogen accelerates the development of estrogen receptor-negative breast cancer. (2013) (0)
Acknowledgement to the Reviewers (2013) (0)
*** Schedule at a Glance*** (10-05-11) (2011) (0)
Steroidogenic acute regulatory protein (StAR) facilitates de novo synthesis of progesterone by human leiomyoma (LEIO) and myometrium (MYO) cells (2009) (0)
Chapter 5 Tissue-specific expression of the CYP19 (aromatase) gene (1998) (0)
James Segars, MD (2016) (0)
Treatment with the aromatase inhibitor letrozole significantly reduced the size of ectopic uterine implants. (2001) (0)
Fenretinide (2016) (0)
Adenomyosis: Single-cell transcriptomic analysis reveals a paracrine mesenchymal-epithelial interaction involving the WNT/SFRP pathway. (2023) (0)
Hypermethylation of a novel CpG island of intron 1 upregulates steroidogenic factor-1 expression in endometriotic stromal cells (2013) (0)
Differences in retinoid uptake and metabolism causes altered paracrine signaling in endometriosis (2012) (0)
Single-Cell RNA Sequencing Reveals Novel Populations of Fibroblasts and Transcriptomic Changes Within Abdominal Skeletal Muscle in a Mouse Model of Aromatase-Induced Inguinal Hernia (2021) (0)
Inhibition of Estrogen Signaling Reverses Established Inguinal Hernias (2021) (0)
Contributors (2019) (0)
Aromatase and Breast Cancer: From Bench to Bedside. (2010) (0)
Regulation of aromatase P450 promoter (II) activity in endometriotic stromal cells by CCAAT/enhancer binding proteins (C/EBPs). (2001) (0)
CCAAT enhancer binding protein beta (C/EBPβ) regulates aromatase P450 expression VIA new cis-acting element in uterine leiomyoma cells (2007) (0)
Endometriotic stromal cells express a molecular pattern consistent with decreased retinoid uptake, metabolism and action (2009) (0)
Introduction to Guest Editor (2013) (0)
The Relationship between Steriod Receptors and Aromatase in the Mouse Brain (2015) (0)
Molecular Effects of Topical Estrogen on Vaginal Granulation Tissue in Postpartum Women (2021) (0)
Estrogen and progesterone are concurrently required for uterine leiomyoma enlargement in a novel in vivo model (2009) (0)
THE NADPH OXIDASE COMPLEX IS IMPORTANT FOR THE EGF AND PDGF SIGNALING PATHWAYS IN HUMAN LEIOMYOMA SMOOTH MUSCLE CELLS (2007) (0)
Special research presentation: molecular signatures of fibroid stem cells (SCs) implicate IGF2 as a potential new target (2014) (0)
Transcriptome analysis of endometrial stroma derived from human induced pluripotent stem cells reveals novel transcription factors essential for endometrial development (2018) (0)
Aberrant regulation of DNA methyltransferase 3B observed in women with endometriosis (2011) (0)
Stem Cells and Uterine Fibroids (2018) (0)
A vitamin A day: the role of vitamin C (ascorbic acid) and ITS transporters in the transcription and secretion of COLIA1 and COLIA2 in leiomyoma and myometrium (2010) (0)
Increased RAR-Related Orphan Receptor Beta Expression Accompanies Altered Retinoid Metabolism During Endometrial Stromal Cell Decidualization. (2011) (0)
Long-term management of symptoms of endometriosis: Treatment options for refractory endometriosis (2012) (0)
SAT-736 Dissecting the Relative Role of Estrogen and Androgen in Fibrosis, Skeletal Muscle Atrophy, and Inguinal Hernia Formation (2020) (0)
208: Novel regulation of fetoplacental vascular blood flow by estrogen receptor-beta (ESR2) (2011) (0)
Introduction to the Guest Editor: Valerie L. Baker, MD (2014) (0)
Steroid Hormones and Receptors STEROID BIOLOGY AND ACTION Dissecting the Relative Role of Estrogen and Androgen in Fibrosis, Skeletal Muscle Atrophy, and Inguinal Hernia Formation (2020) (0)
Defect of Stroma-Epithelial Interaction in Endometriosis is Responsible for Lack of Induction of 17β-Hydroxsteroid Dehydrogenase Type 2 by Progesterone (2005) (0)
Steroid Hormones and Receptors (2022) (0)
microRNAs exhibit high frequency genomic alterations in human cancerZhang L, Huang J, Yang N, et al (Univ of Pennsylvania, Philadelphia; Univ of Turin, Italy; Democritus Univ of Thrace, Alexandroupolis, Greece) Proc Natl Acad Sci U S A 103:9136–9141, 2006§ (2007) (0)
MeDEStrand: an improved method to infer genome-wide absolute methylation levels from DNA enrichment data (2018) (0)
AD Award Number DAMD 1797-17025 TITLE : Adipocyte Differentiation : Relationship to Breast Cancer (0)
Jeanne Sheffield, MD (2016) (0)
CASE SEMINAR Expression in a Feminizing Adrenocortical (1996) (0)
RF03 | PMON300 Sex Hormones, Sex Hormone Binding Globulin, and Gonadotropins in Men with Inguinal Hernias (2022) (0)
ERβ Regulates Genes That Have Kinase and GTPase Functions and Enhance Cell Survival in Endometriosis. (2012) (0)
Interrogating Altered DNA Methylation in Human Endometriotic Stromal Cells. (2012) (0)
Steven L. Young, MD, PhD, FACOG (2014) (0)
Fenretinide as a novel treatment for endometriosis (2012) (0)
Adipocyte Differentiation: Relationship to Breast Cancer. (1998) (0)
Expression of hypoxia inducible factors and differential impact of hypoxia on the major fibrillar collagens in leiomyoma cells (2013) (0)
Egr-1 inhibits the induction of 17-βHSD type 2 gene by Sp1 or Sp3 in human endometrial epithelial cells (2002) (0)
Endometriotic Stromal Cells Methylation of a Novel CpG Island of Intron 1 Is Associated With Steroidogenic Factor 1 Expression in - (2013) (0)
A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts. VOLUME 281 (2006) PAGES 2585-2597 (2006) (0)
9. Progesterone Resistance in Endometriosis and its Epigenetic Origins(Meet the Professor,International Symposium) (2008) (0)
Treatment with Aromatase Inhibitors (2003) (0)
Oocyte Generation in Adult Mammalian Ovaries by Putative Germ Cells in Bone Marrow and Peripheral Blood (2007) (0)
Infundibulum Uterine tube Ovary Cervix Vagina Perimetrium Fimbriae Fundus Uterus (2009) (0)
Pesticide Use and Menstrual Cycle Characteristics Among Premenopausal Women in the Agricultural Health Study (2006) (0)
The aberrant expression and localization of DNA methyltransferase 3B in endometriotic stromal cells (2015) (0)
Intact progesterone receptors are essential to counteract the proliferative effect of estrogen in a transgenic mouse model of endometriosis (2002) (0)
SAT-747 A Prospective Non-surgical Treatment for Inguinal Hernias (2020) (0)
Transcriptome analysis of endometrial stroma-like organoids differentiated from human induced pluripotent stem cells (2017) (0)
Aromatase gene expression in uterine leiomyoma from African-American women is dramatically higher compared with other races (2008) (0)
Progesterone-dependent induction of STRA6 regulates retinoic acid action in the endometrium (2008) (0)
Hormone manipulation: The future for cancer treatment? Hormones and cancer Edited by Wayne V. Vedeckis. Boston, Birkhäuser, 1996, $99.00 (xix + 612 pages), ISBN 0-8176-3797-4 (1997) (0)
Great Lakes Nuclear Receptor Conference ( GLNRC ) (2012) (0)
Transcriptome analysis of endometrial stroma-like cells derived from human induced pluripotent stem cells identifies a potential endometrial stem cell marker (2018) (0)
An estrogen-sensitive fibroblast population drives abdominal muscle fibrosis in an inguinal hernia mouse model (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Serdar Ekrem Bulun?

Serdar Ekrem Bulun is affiliated with the following schools:

Serdar Ekrem Bulun's Academic­Influence.com Rankings